AMAL SAHA: Open Payments
NPI 1003861220 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,919 in 117 payments from 9 companies in 2025. Trend: 2023 $2,139 · 2024 $1,787 · 2025 $2,919
Food & beverage: $2,919
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 25 | $540 |
| Lundbeck LLC | 18 | $513 |
| Otsuka America Pharmaceutical, Inc. | 22 | $464 |
| E.R. Squibb & Sons, L.L.C. | 13 | $454 |
| Janssen Pharmaceuticals, Inc | 15 | $448 |
| Neurocrine BioSciences, Inc. | 9 | $245 |
| Teva Pharmaceuticals USA, Inc. | 12 | $170 |
| ABBVIE INC. | 2 | $58 |
| Luye Pharma (USA) Ltd. | 1 | $26 |
Products named: ABILIFY ASIMTUFII, COBENFY, INVEGA SUSTENNA, ARISTADA, INGREZZA, VIVITROL, UZEDY, ABILIFY MAINTENA.
Industry payments across NY — which companies pay providers there.
